Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04206215 · ClinicalTrials.gov registry record · NA

Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome

A NA study of Chronic Pain and Carpal Tunnel Syndrome, sponsored by Spaulding Rehabilitation Hospital.

Recruiting
Registry status
NA
Development phase
95
Enrollment target
1
Study location

NCT04206215 is a NA study of Chronic Pain and Carpal Tunnel Syndrome that is actively recruiting participants, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 95 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04206215, a NA study of Chronic Pain and Carpal Tunnel Syndrome, is actively recruiting participants, sponsored by Spaulding Rehabilitation Hospital.

RECRUITING
Registry status
NA
Development phase
95 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the effects of tDCS in combination with TUS for the treatment of pain in subjects with Carpal Tunnel Syndrome. The investigators hypothesize that there will be a decrease in pain levels with active stimulation, when compared to sham stimulation.

Interventions

  • DEVICE transcranial Direct Current Stimulation (tDCS)
  • DEVICE Transcranial Ultrasound (TUS)

Study Locations (1)

Massachusetts

  • Spaulding Rehabilitation Network Research Institute - Charlestown

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2021-04-16
Est. Completion 2027-02-28
Phase NA

Sponsor

Spaulding Rehabilitation Hospital

101 total trials

What the Registry Record Tells You About NCT04206215

The ClinicalTrials.gov registry entry for NCT04206215 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (88% lower). The listed sponsor is Spaulding Rehabilitation Hospital, which has 101 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which transcranial Direct Current Stimulation (tDCS) is the first listed.

NCT04206215 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04206215 about?

NCT04206215 is a clinical study titled "Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome". The purpose of this study is to assess the effects of tDCS in combination with TUS for the treatment of pain in subjects with Carpal Tunnel Syndrome. The investigators hypothesize that there will be a decrease in pain levels with active stimulation, when compared to sham stimulation.

What is the current status of trial NCT04206215?

This trial is currently recruiting. It is a NA study. The enrollment target is 95 participants. The study started on 2021-04-16. Estimated completion is 2027-02-28.

What conditions does trial NCT04206215 study?

This clinical trial studies the following conditions: Chronic Pain, Carpal Tunnel Syndrome.

What interventions are being tested in trial NCT04206215?

The interventions under investigation include: transcranial Direct Current Stimulation (tDCS) (DEVICE), Transcranial Ultrasound (TUS) (DEVICE).

Who is sponsoring clinical trial NCT04206215?

This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04206215 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.